Evidence map›Paper›PMID 25560046›Full record

ReviewBritish journal of pharmacology2015

Transdermal patches: history, development and pharmacology.

Michael N Pastore, Yogeshvar N Kalia, Michael Horstmann, Michael S Roberts

Registry-linked trialAbstract readHistorical ArticleReview
In one paragraph

Review in British journal of pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04651426 (Use of a Non-medicated Plaster in Chronic Lumbar Back Pain.), which is not on this map. Cited by 146 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04651426 nacompletednot on this mapstarted 2019, after this paper: background citation

Use of a Non-medicated Plaster in Chronic Lumbar Back Pain.

TypeinterventionalSponsorAzienda Ospedaliera Universitaria Integrata VeronaRan2019 to 2019Enrolled54ConditionsBack PainArmsThe FIT Therapy patch (D. FENSTEC s.r.l. Altavilla Vicentina, Italy) is a medical device class 1
3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. ACMT and AACT Position Statement: Preventing Occupational Fentanyl and Fentanyl Analog Exposure to Emergency Responders.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2017
    Guideline
  2. Trial
  3. Efficacy of a novel microneedle patch for rejuvenation of the nasolabial fold.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2022
    Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael N PastoreSchool of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia.
Yogeshvar N Kalia
Michael Horstmann
Michael S Roberts

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transdermal patches are now widely used as cosmetic, topical and transdermal delivery systems. These patches represent a key outcome from the growth in skin science, technology and expertise developed through trial and error, clinical observation and evidence-based studies that date back to the first existing human records. This review begins with the earliest topical therapies and traces topical delivery to the present-day transdermal patches, describing along the way the initial trials, devices and drug delivery systems that underpin current transdermal patches and their actives. This is followed by consideration of the evolution in the various patch designs and their limitations as well as requirements for actives to be used for transdermal delivery. The properties of and issues associated with the use of currently marketed products, such as variability, safety and regulatory aspects, are then described. The review concludes by examining future prospects for transdermal patches and drug delivery systems, such as the combination of active delivery systems with patches, minimally invasive microneedle patches and cutaneous solutions, including metered-dose systems.

Indexed as

Chemistry, PharmaceuticalTransdermal PatchAdministration, CutaneousAnimalsDrug CarriersHistory, 15th CenturyHistory, 18th CenturyHistory, 19th CenturyHistory, 20th CenturyHistory, 21st CenturyHistory, AncientHumansPharmaceutical PreparationsTechnology, PharmaceuticalDrug CarriersPharmaceutical Preparations

Identifiers

PMID25560046
PMCPMC4403087

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.